Select Publications
Conference Papers
2002, '<title>Optimized laser application in dermatology using infrared thermography</title>', in Maldague XP; Rozlosnik AE (ed.), SPIE Proceedings, SPIE, pp. 424 - 434, presented at AeroSense 2002, http://dx.doi.org/10.1117/12.459592
,1998, 'Activity-dependentconduction block in human axons', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S78 - S78, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998
,1998, 'Mechanisms of conduction slowing in carpal tunnel syndrome', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S95 - S95, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998
,1998, 'Pathophysiology of entrapment and compression neuropathies', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S81 - S81, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998
,1997, 'Axonal ion channel abnormality in amyotrophic lateral sclerosis', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 167 - 168, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997
,1997, 'Excitability changes and paraesthesiae following high-frequency stimulation of human cutaneous afferents', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 39 - 39, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997
,1997, 'Ion channel abnormality in motor axons in amyotrophic lateral sclerosis', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 402 - 403, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997
,1997, 'Vagrant behaviour of hyperstimulated cutaneous afferent axons: a mechanism for paraesthesiae', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 397 - 397, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997
,1996, 'Strength-duration properties of cutaneous afferents in motor neuron disease', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 62P - 62P, presented at 7th Biennial Clin Neurophysiol Workshop, Southport, Qld, 30 September 1996 - 02 October 1996
,1992, 'A COMPARISON OF PLAIN RADIOLOGY AND FLOW VOLUME LOOP CURVES IN PATIENTS WITH GOITERS', in JOURNAL OF PHYSIOLOGY-LONDON, CAMBRIDGE UNIV PRESS, pp. P432 - P432, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992HD60500423&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Presentations
2010, 'The effects of focal nerve compression in carpal tunnel syndrome', presented at 11th Triennial Congress of the International Federation of Societies for Surgery of the Hand, Seoul, Korea, 31 October 2010 - 04 November 2010
,2010, 'Hyperexcitability, persistent Na+ conductances and ndurodegeneration in motor neurone disease', presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
,2008, 'Inspirational (Inspiratory Training in Amyotrophic Lateral Sclerosis)', presented at Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2008, Brisbane, 19 May 2008 - 23 May 2008
,Conference Abstracts
2022, 'Development and consensus of 'CIPN-path': A clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 190 - 190, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Assessing chemotherapy-induced peripheral neuropathy - A psychometric analysis of current approaches', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 11 - 11
,2020, 'Dose modification: Does it affect follow-up outcomes in taxane-induced neuropathy?', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 480 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Patient reported outcome scores used in chemotherapy-induced peripheral neuropathy: Defining minimal important differences', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 481 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, '009 Axonal excitability properties in dravet’s syndrome reflect effect of loss of sodium channels', in Journal of Neurology, Neurosurgery & Psychiatry, BMJ, Vol. 90, pp. A4.1 - A4, http://dx.doi.org/10.1136/jnnp-2019-anzan.9
,2018, 'Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, MD, Baltimore, Vol. 23, pp. 275 - 275, presented at Annual Meeting of the Peripheral-Nerve-Society, MD, Baltimore, 21 July 2018 - 25 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000452787700066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'CORTICAL HYPEREXCITABILITY MAY CONTRIBUTE TO DISEASE SPREAD IN ALS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.20
,2017, 'FUNCTIONAL AND STRUCTURAL CONNECTIVITY IN ALS: INSIGHTS FROM MRI CONNECTOME ANALYSES AND TMS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.21
,2016, 'Evidence from human studies for spreading/staging of TDP-43 pathology in FTLD and ALS', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, Vol. 138, pp. 235 - 235, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, Vol. 138, pp. 367 - 367, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Theses / Dissertations
1997, Activity-dependent changes in axonal excitability
,Preprints
2024, Peripheral Neuropathy in Cancer Patients- Multifactorial Contributors to Dose Limiting and Chronic Toxicity, http://dx.doi.org/10.1101/2024.07.24.24310956
,2022, Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial., http://dx.doi.org/10.21203/rs.3.rs-2125381/v1
,2021, Cortical hyperexcitability drives dying forward ALS symptoms and pathology in mice, http://dx.doi.org/10.1101/2021.08.13.456320
,2021, Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology, http://dx.doi.org/10.1101/2021.03.12.21253159
,2021, Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology, http://dx.doi.org/10.21203/rs.3.rs-322430/v1
,2021, Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways, http://dx.doi.org/10.1101/2021.03.12.21253115
,2019, IBD analysis of Australian amyotrophic lateral sclerosis SOD1-mutation carriers identifies five founder events and links sporadic cases to existing ALS families, http://dx.doi.org/10.1101/685925
,Safety and Tolerability of Triumeq in Amyotrophic Lateral Sclerosis: The Lighthouse Trial, http://dx.doi.org/10.2139/ssrn.3347916
,Other
2017, Author response: Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study, http://dx.doi.org/10.1212/WNL.0000000000003628
,